13F filer · CIK 1009207 ↗
D. E. Shaw
You are looking at Q2 2019. See the latest, Q2 2026 →
Reported value
$80.19B
+3.6% on the quarter before
Positions
3,632
524 new · 441 sold out
Top 10
9.8%
of the value
Est. gain
+$921.2M
on stocks held all quarter
Est. return
+2.0%
on those stocks since Q1 2019
Positions as of Jun 30, 2019, from D. E. Shaw's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 18% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2019. Striped tiles are options.
Largest buys
Since Q1 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Alibaba~$655.2MAdded · 0.5% → 1.3%+3,866,508 shares
- Nvidia~$578.9MAdded · 0.1% → 0.8%+3,524,789 shares
- Amazon~$425.0MAdded · 0.6% → 1.1%+224,436 shares
- Conocophillips~$423.5MAdded · 0.5% → 1.0%+6,942,095 shares
- Johnson & Johnson~$379.8MAdded · 0.6% → 1.1%+2,726,614 shares
- Anadarko Pete Corp~$365.9MAdded · 0.2% → 0.7%+5,185,196 shares
- Biogen Inc~$356.5MAdded · 0.3% → 0.8%+1,524,355 shares
- Microsoft~$310.2MAdded · 0.6% → 1.0%+2,315,955 shares
- Union Pacific Corp~$223.7MAdded · 0.1% → 0.4%+1,323,006 shares
- Procter And Gamble Co~$204.5MAdded · 0.1% → 0.4%+1,865,310 shares
Largest sells
Since Q1 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Qualcomm~$868.3MCut · 0.9% → 0.0%−11,413,720 shares
- Meta~$554.1MCut · 1.0% → 0.5%−2,871,023 shares
- Apple~$460.5MCut · 1.4% → 0.9%−2,326,765 shares
- Celgene Corp~$339.5MCut · 0.9% → 0.4%−3,672,266 shares
- Pfizer Inc~$316.4MCut · 0.6% → 0.2%−7,302,650 shares
- Ebay Inc~$284.5MCut · 0.6% → 0.3%−7,202,979 shares
- Oracle~$271.8MCut · 0.6% → 0.3%−4,770,890 shares
- MetaPUT~$212.4MCut · 0.3% → 0.1%−1,100,500 underlying
- AlibabaCALL~$184.4MCut · 0.3% → 0.0%−1,088,100 underlying
- Walt Disney Company (The)~$178.7MCut · 0.4% → 0.2%−1,280,068 shares
Holdings
As of Jun 30, 2019. Changes are in shares against Mar 31, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AlibabaSPONSORED ADS · shares +166% · price −7.1% | 1.3% | $1.05B | −$30.3M | ||||||||
| AmazonCOM · shares +92% · price +6.3% | 1.1% | $888.4M | +$27.6M | ||||||||
| Johnson & JohnsonCOM · shares +81% · price −0.4% | 1.1% | $847.0M | −$1.7M | ||||||||
| MicrosoftCOM · shares +61% · price +13.6% | 1.0% | $817.0M | +$60.6M | ||||||||
| ConocophillipsCOM · shares +115% · price −8.6% | 0.99% | $792.0M | −$34.7M | ||||||||
| Lowes Cos IncCOM · shares −13% · price −7.8% | 0.95% | $761.9M | −$64.6M | ||||||||
| AmazonPUTCOM · shares +9.1% | 0.89% | $717.7M | — | ||||||||
| AppleCOM · shares −40% · price +4.2% | 0.86% | $692.1M | +$27.9M | ||||||||
| Verisign IncCOM · shares −0.3% · price +15.2% | 0.84% | $674.8M | +$89.0M | ||||||||
| NvidiaCOM · shares +912% · price −8.5% | 0.80% | $642.3M | −$5.9M | ||||||||
| Biogen IncCOM · shares +145% · price −1.1% | 0.75% | $601.7M | −$2.6M | ||||||||
| Anadarko Pete CorpCOM · shares +181% · price +55.1% | 0.71% | $567.5M | +$71.7M | ||||||||
| Wells Fargo Co NewCOM · shares +62% · price −2.1% | 0.66% | $531.2M | −$6.9M | ||||||||
| Medtronic PlcSHS · shares +21% · price +6.9% | 0.65% | $519.4M | +$27.8M | ||||||||
| Fidelity Natl Information SvCOM · shares +4.3% · price +8.5% | 0.64% | $512.4M | +$38.4M | ||||||||
| Abbvie IncCOM · shares +4.9% · price −9.8% | 0.58% | $464.8M | −$48.0M | ||||||||
| Visa Inc.COM CL A · shares +64% · price +11.1% | 0.58% | $463.0M | +$28.3M | ||||||||
| MercadoLibreCOM · shares +0.9% · price +20.5% | 0.53% | $421.6M | +$71.0M | ||||||||
| Colgate Palmolive CoCOM · shares −26% · price +4.6% | 0.52% | $419.5M | +$18.3M | ||||||||
| Gilead Sciences IncCOM · shares −3.4% · price +3.9% | 0.52% | $417.8M | +$15.8M | ||||||||
| Merck & Co IncCOM · shares −17% · price +0.8% | 0.52% | $415.3M | +$3.4M | ||||||||
| Starbucks CorpCOM · shares +12% · price +12.8% | 0.50% | $402.3M | +$40.5M | ||||||||
| Mcdonalds CorpCOM · shares +38% · price +9.4% | 0.48% | $388.1M | +$24.0M | ||||||||
| Caterpillar Inc DelCOM · shares +47% · price +0.6% | 0.48% | $387.5M | +$1.5M | ||||||||
| Honeywell TechnologiesCOM · shares +78% · price +9.9% | 0.48% | $381.9M | +$19.2M | ||||||||
| Total · 3,632 positions | 100% | $80.19B | +$921.2M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2019 to Q2 2019: 2,219 stocks held throughout, up $921.2M (+2.0%).
- Verisign Inc+$89.0M+15%
- Anadarko Pete Corp+$71.7M+55%
- MercadoLibre+$71.0M+20%
- Microsoft+$60.6M+14%
- Exact Sciences Corp+$51.3M+36%
- Baidu−$46.4M−29%
- Abbvie Inc−$48.0M−10%
- Eqt Corp−$54.4M−24%
- Kar Auction Svcs Inc−$57.9M−51%
- Lowes Cos Inc−$64.6M−8%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 6 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $210.20B+26% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $166.31B−9% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $182.42B+3% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $177.16B+26% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $141.06B+26% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $112.35B−18% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $136.27B+17% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $116.49B+9% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $106.92B−8% | SEC ↗ |
| Q1 2024 | May 15, 2024 (amended) | $116.85B+2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 (amended) | $114.44B+19% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $95.78B−2% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $97.90B+5% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $93.41B+3% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $90.48B+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $83.73B−2% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $85.30B−20% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $106.83B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $120.60B+9% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $110.81B−4% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $115.86B+12% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $103.59B−7% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $111.85B+14% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $97.71B+16% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $83.95B+31% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $64.09B−27% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $87.45B+8% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $81.21B+1% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $80.19B+4% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $77.39B+7% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $72.58B−13% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $83.24B+9% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $76.66B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $73.46B+1% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $72.62B+12% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $65.09B+8% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $60.46B+6% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $56.89B−3% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $58.87B+4% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $56.68B+5% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $54.23B−3% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $55.73B | SEC ↗ |